Wellness Daily Nauru: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Daily Nauru.

Press releases published on October 7, 2026

3 hours ago

AIM ImmunoTech’s Strategy to Address Immune Resistance in Pancreatic Cancer Featured in BioTuesdays

Indeterminate GlobeNewswire

3 hours ago

BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting

Indeterminate GlobeNewswire

3 hours ago

Integrity Care Group Enters Two New States and Strengthens Core Market with Acquisition of 15 NextCare Clinics; Now Offers Access to High-Quality Healthcare in 100 Clinics Across Five States

Indeterminate GlobeNewswire

3 hours ago

Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform

Indeterminate GlobeNewswire

3 hours ago

Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit

Indeterminate GlobeNewswire

3 hours ago

Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program

Indeterminate GlobeNewswire

3 hours ago

Tria Federal Launches Healthcare Trilemma Campaign to Open a New Conversation in Federal Health

Indeterminate GlobeNewswire

3 hours ago

Commure Appoints Nick Apeland as President of Go-to-Market

Indeterminate GlobeNewswire

3 hours ago

Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA

Indeterminate GlobeNewswire

3 hours ago

NetraMark Founder Dr. Joseph Geraci to Participate in H.C. Wainwright’s AI-Based Drug Discovery and Development Conference

Indeterminate GlobeNewswire

3 hours ago

Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio

Indeterminate GlobeNewswire

3 hours ago

SEMA4D Blockade Reshapes the Tumor Immune Environment in Neoadjuvant Melanoma Study

Indeterminate GlobeNewswire

3 hours ago

Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million

Indeterminate GlobeNewswire

3 hours ago

Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications

Indeterminate GlobeNewswire

3 hours ago

OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific Region

Indeterminate GlobeNewswire

3 hours ago

RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial

Indeterminate GlobeNewswire

3 hours ago

Theialife Announces Positive Type C Meeting with FDA for ND10 in Progressive Myopia

Indeterminate GlobeNewswire

3 hours ago

TOMI Environmental Solutions Confirms Readiness to Support Biosecurity Preparedness and Front-Line Response Worldwide

Indeterminate GlobeNewswire

3 hours ago

Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines’ Daraxonrasib

Indeterminate GlobeNewswire

3 hours ago

Cyllene Therapeutics Presents Interim Data from Phase 1b/2a Clinical Trial Showing EG110A Reduced Urinary Episodes in Patients with Spinal Cord Injury at the International Continence Society (ICS) Conference

Indeterminate GlobeNewswire